CONTENTS:
- What are the implications of the steady 40 year rise in US fatal overdoses?: Introduction to a special section. Reuter P., art. 103693.
- Exponential increases in drug overdose: Implications for epidemiology and research. Compton W.M., Einstein E.B., Jones C.M., art. 103676.
- Dynamics of drug overdose in the 20th and 21st centuries: The exponential curve was not inevitable, and continued increases are preventable. Keyes K.M., Cerda M., art. 103675.
- Fatal overdose: Predicting to prevent. Borquez A., Martin N.K., art. 103677.
- Should drug use trends be studied holistically, or piece by piece? Caulkins J.P., art. 103673.
- Reply commentary by Jalal and Burke. Burke D.S., Jalal H., art. 103674.
- The United Kingdom's first unsanctioned overdose prevention site; A proof-of-concept evaluation. Shorter G.W., Harris M., McAuley A., Trayner K.M.A., Stevens A., art. 103670.
- A qualitative comparison of how people who use drugs' perceptions and experiences of policing affect supervised consumption services access in two cities. Urbanik M.-M., Maier K., Greene C., art. 103671.
- Police officers' attitudes and practices toward harm reduction services in Sweden - a qualitative study. Nordgren J., Richert T., Stallwitz A., art. 103672.
- The introduction of fentanyl on the US-Mexico border: An ethnographic account triangulated with drug checking data from Tijuana. Friedman J., Bourgois P., Godvin M., Chavez A., Pacheco L., Segovia L.A., et al., art. 103678.
- Temporal monitoring of stimulants during the COVID-19 pandemic in Belgium through the analysis of influent wastewater. Boogaerts T., Quireyns M., De prins M., Pussig B., De Loof H., Matheï C., et al., art. 103679.
- Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions. Bouck Z., Scheim A.I., Gomes T., Ling V., Caudarella A., Werb D., art. 103680.
- Alcohol everywhere, anytime, coming to a world near you. Pettigrew S., art. 103681.
- A pilot implementation study to scale-up methadone in incarcerated persons with opioid use disorder and retain them on treatment after release in Moldova. Dorgay C.E., Bromberg D.J., Doltu S., Litz T., Galvez S., Polonsky M., et al., art. 103683.
- Impact of cannabis legalization on healthcare utilization for psychosis and schizophrenia in Colorado. Wang G.S., Buttorff C., Wilks A., Schwam D., Tung G., Pacula R.L., art. 103685.
- Shifting of opioid prescription rate reporting impacts both rural and urban counties. Hudnall M., Parton J., Lewis D., art. 103686.
- Between zero risk and harm reduction: An ethnography of Montreal supervised injection services as a public policy instrument. Paumier R., art. 103694.
- Lead poisoning among asymptomatic individuals with a long-term history of opiate use in Golestan Cohort Study. Etemadi A., Hariri S., Hassanian-moghaddam H., Poustchi H., Roshandel G., Shayanrad A., et al., art. 103695.
- Hepatitis C antibody testing among opioid agonist therapy recipients, Victoria, Australia, 2012 to 2020. Dawe J., Wilkinson A.L., Asselin J., Carter A., Pedrana A., Traeger M.W., et al., art. 103696.
- Double shifts, double trouble: Alcohol as a problematic panacea for working mothers. Caluzzi G., Wright C., Kuntsche E., Stewart S.H., Kuntsche S., art. 103699.